Previous studies have suggested that HER2-low breast cancer may display distinct metabolic traits in contrast to HER2-0 tumors,40,41 suggesting a possible association between metabolism-related mutations and HER2-low breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.